Greenwich LifeSciences, Inc. (GLSI)
Nasdaq: GLSI · Pharmaceutical Preparations · Stafford, TX · filing with the SEC since 2020
Filings
133 filings since 2017 beside 146 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 26, 2026.
Filings a yearinsider forms included
74205944422614
2026 counts to Nov 13, 2026.
Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Jul 24, 2025.SEC letters: 2 in the last 36 months, the newest Oct 15, 2024.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2024.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 17, 2024
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Jun 13, 2024
40 of 133 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.